金力永磁(300748.SZ):正積極配合世界知名客户的人形機器人用磁組件的研發,並且陸續有小批量的交付
格隆匯11月12日丨金力永磁(300748.SZ)於2024年11月12日接受特定對象調研,就“公司在人形機器人領域的業務進展?”,公司表示,人形機器人是未來高性能釹鐵硼磁材重要需求增長點之一,公司把握時代的潮流,正積極配合世界知名客户的人形機器人用磁組件的研發,並且陸續有小批量的交付,但現階段對公司收入和盈利影響甚微。有關具體客户的具體業務等情況,公司將基於與客户簽署的保密協議基礎上,嚴格遵守相關法律法規,做好信息披露工作,目前公司不存在應披露而未披露的事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.